Archive for precision medicine

Diversity is good in populations of people, but when it comes to cancer, it’s bad news. In the case of medulloblastoma—the most common malignant brain cancer in children—tumor diversity has been one of the greatest barriers to designing effective treatments. Now, in the largest genomic study of human medulloblastomas ever, Children’s researchers and their collaborators ... Read More about Childhood brain cancer: Learning to divide and conquer